← Back to Screener
cbdMD, Inc. Common Stock (YCBD)
Price$0.81
Favorite Metrics
Price vs S&P 500 (26W)-44.52%
Price vs S&P 500 (4W)6.68%
Market Capitalization$7.12M
All Metrics
Book Value / Share (Quarterly)$0.89
P/TBV (Annual)2.11x
Revenue Growth (3Y)-18.46%
Cash Flow / Share (Quarterly)$-0.21
Price vs S&P 500 (YTD)-45.62%
Gross Margin (TTM)60.59%
Net Profit Margin (TTM)-12.25%
EPS (TTM)$-0.88
10-Day Avg Trading Volume0.26M
EPS Excl Extra (TTM)$-0.88
Revenue Growth (5Y)-14.45%
EPS (Annual)$-0.51
Dividend / Share (Annual)$0.00
ROI (Annual)-28.24%
Gross Margin (Annual)62.37%
Net Profit Margin (5Y Avg)-75.03%
Cash / Share (Quarterly)$0.34
Revenue Growth QoQ (YoY)-1.89%
ROA (Last FY)-19.59%
Revenue Growth TTM (YoY)-0.66%
EBITD / Share (TTM)$-0.21
ROE (5Y Avg)-143.31%
Operating Margin (TTM)-12.37%
Cash Flow / Share (Annual)$-0.18
P/B Ratio0.79x
P/B Ratio (Quarterly)1.34x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)0.20x
Net Interest Coverage (TTM)-7.06x
ROA (TTM)-21.74%
EV / EBITDA (TTM)0.31x
EPS Incl Extra (Annual)$-0.51
Current Ratio (Annual)2.05x
Quick Ratio (Quarterly)1.62x
3-Month Avg Trading Volume7.88M
52-Week Price Return-54.07%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.70
P/S Ratio (Annual)0.37x
Asset Turnover (Annual)1.84x
52-Week High$2.56
Operating Margin (5Y Avg)-74.98%
EPS Excl Extra (Annual)$-0.51
CapEx CAGR (5Y)-32.56%
Tangible BV CAGR (5Y)-20.44%
26-Week Price Return-35.77%
Quick Ratio (Annual)1.03x
13-Week Price Return-26.17%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)2.94x
Enterprise Value$3.73
Revenue / Share Growth (5Y)-35.24%
Asset Turnover (TTM)1.77x
Book Value / Share Growth (5Y)-58.51%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)2.83x
Pretax Margin (Annual)-10.63%
Cash / Share (Annual)$0.25
3-Month Return Std Dev130.68%
Gross Margin (5Y Avg)63.30%
Net Income / Employee (TTM)$-0
ROE (Last FY)-28.24%
Net Interest Coverage (Annual)-8.49x
EPS Basic Excl Extra (Annual)$-0.51
Receivables Turnover (TTM)15.97x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.88
Receivables Turnover (Annual)18.96x
ROI (TTM)-40.66%
P/S Ratio (TTM)0.37x
Pretax Margin (5Y Avg)-75.43%
Revenue / Share (Annual)$4.77
Tangible BV / Share (Annual)$0.57
Price vs S&P 500 (52W)-89.16%
Year-to-Date Return-41.48%
5-Day Price Return6.04%
EPS Normalized (Annual)$-0.51
ROA (5Y Avg)-77.34%
Net Profit Margin (Annual)-10.63%
Month-to-Date Return6.47%
Cash Flow / Share (TTM)$-15.00
EBITD / Share (Annual)$-0.26
Operating Margin (Annual)-11.27%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-129.07%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.88
P/TBV (Quarterly)1.71x
P/B Ratio (Annual)1.49x
Dividend / Share (TTM)$0.00
Inventory Turnover (TTM)2.95x
Pretax Margin (TTM)-12.25%
Book Value / Share (Annual)$0.81
Price vs S&P 500 (13W)-29.03%
Dividend Yield (TTM)0.00%
Beta2.07x
Revenue / Share (TTM)$2.12
ROE (TTM)-40.66%
52-Week Low$0.47
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.14
4.14
4.14
4.14
Industry Peers — Cosmetics & Toiletries(15)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
YCBDcbdMD, Inc. Common Stock | 0.37x | -0.66% | 60.59% | — | $0.81 |
CLColgate-Palmolive Company | 3.29x | 1.40% | 60.11% | -3.48% | $83.53 |
HLNHaleon plc American Depositary Shares (Each representing two Ordinary Shares) | 2.90x | -1.81% | 64.69% | 8.30% | $9.68 |
KVUEKenvue Inc. | 2.23x | -2.14% | 58.62% | — | $17.58 |
ELThe Estee Lauder Companies Inc. Class A | 1.89x | -3.35% | 74.33% | — | $77.85 |
ELFe.l.f. Beauty, Inc. | 2.66x | 16.73% | 70.27% | 40.38% | $68.42 |
IPARInterparfums, Inc. Common Stock | 2.12x | 2.49% | 55.46% | 34.17% | $98.01 |
COTYCOTY INC | 1.74x | 9.07% | 63.93% | — | $2.37 |
OLPXOlaplex Holdings, Inc. Common Stock | 3.21x | 0.07% | 70.75% | -20.80% | $2.04 |
EPCEdgewell Personal Care Company | 0.51x | -3.36% | 41.52% | -15.49% | $23.57 |
WALDWaldencast plc Class A Ordinary Share | 0.33x | -0.27% | 68.13% | — | $1.03 |
About
cbdMD Inc is a United States-based consumer wellness company that manufactures and distributes CBD and functional mushroom products through three distinct brands: cbdMD, Paw CBD (pet-focused), and ATRx Labs. Its product portfolio includes tinctures, gummies, topicals, capsules, oils, and pet formulations distributed via e-commerce, wholesalers, and retail partnerships. This diversified brand and channel strategy positions the company across multiple consumer wellness segments.